Neogen (NEOG) Debt to Equity (2011 - 2026)
Neogen's quarterly Debt to Equity came in at $0.38 in Q1 2026, up 12.71% year-on-year from $0.33 in Q1 2025, and little changed quarter-over-quarter from $0.38 in Q4 2025.
Neogen has reported Debt to Equity for 12 years, with the latest figure at $0.38 in Q1 2026.
- For the quarter ending Q1 2026, Debt to Equity rose 12.71% year-over-year to $0.38; the trailing twelve-month figure through Feb 2026 stood at $0.38 (up 12.71% YoY), and the FY2025 full-year result was $0.43, up 52.36% from the prior year.
- Debt to Equity for Q1 2026 stood at $0.38, roughly flat from $0.38 in the prior quarter.
- The five-year high for Debt to Equity was $0.43 in Q2 2025, with the low at $0.28 in Q3 2023.
- Average Debt to Equity over 5 years is $0.32, with a median of $0.29 recorded in 2022.
- Year-over-year, Debt to Equity declined 5.27% in 2023 and jumped 52.36% in 2025.
- Tracing NEOG's Debt to Equity over 5 years: stood at $0.3 in 2022, then decreased by 5.27% to $0.28 in 2023, then increased by 18.32% to $0.33 in 2024, then grew by 13.01% to $0.38 in 2025, then advanced by 0.14% to $0.38 in 2026.
- The last three Debt to Equity figures came in at $0.38 (Q1 2026), $0.38 (Q4 2025), and $0.37 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.27 |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn | 0.38 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 0.38 |
| Nov 30, 2025 | 0.38 |
| Aug 31, 2025 | 0.37 |
| May 31, 2025 | 0.43 |
| Feb 28, 2025 | 0.33 |
| Nov 30, 2024 | 0.33 |
| Aug 31, 2024 | 0.28 |
| May 31, 2024 | 0.28 |
| Feb 29, 2024 | 0.28 |
| Nov 30, 2023 | 0.28 |
| Aug 31, 2023 | 0.28 |
| May 31, 2023 | 0.28 |
| Feb 28, 2023 | 0.28 |
| Nov 30, 2022 | 0.30 |
| Feb 28, 2017 | 0.01 |
| Nov 30, 2016 | 0.01 |
| Aug 31, 2016 | 0.01 |
| May 31, 2016 | 0.01 |
| Feb 29, 2016 | 0.01 |
| Nov 30, 2015 | 0.01 |
| Aug 31, 2015 | 0.01 |
| May 31, 2015 | 0.01 |
| Feb 28, 2015 | 0.01 |
| Nov 30, 2014 | 0.01 |
| Aug 31, 2014 | 0.01 |
| May 31, 2014 | 0.01 |
| Feb 28, 2014 | 0.01 |
| Nov 30, 2013 | 0.01 |
| Aug 31, 2013 | 0.01 |
| May 31, 2013 | 0.01 |
| Feb 28, 2013 | 0.01 |
| Nov 30, 2012 | 0.01 |
| Aug 31, 2012 | 0.01 |
| May 31, 2012 | 0.01 |
| Feb 29, 2012 | 0.02 |
| Nov 30, 2011 | 0.02 |
| Aug 31, 2011 | 0.02 |
| May 31, 2011 | 0.02 |